JP2024544953A5 - - Google Patents

Info

Publication number
JP2024544953A5
JP2024544953A5 JP2024527703A JP2024527703A JP2024544953A5 JP 2024544953 A5 JP2024544953 A5 JP 2024544953A5 JP 2024527703 A JP2024527703 A JP 2024527703A JP 2024527703 A JP2024527703 A JP 2024527703A JP 2024544953 A5 JP2024544953 A5 JP 2024544953A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutically acceptable
formula
unsubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/049369 external-priority patent/WO2023086365A1/en
Publication of JP2024544953A publication Critical patent/JP2024544953A/ja
Publication of JP2024544953A5 publication Critical patent/JP2024544953A5/ja
Pending legal-status Critical Current

Links

JP2024527703A 2021-11-11 2022-11-09 アミノ脂質化合物を含む組成物ならびにその製造方法及び使用方法 Pending JP2024544953A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163278274P 2021-11-11 2021-11-11
US63/278,274 2021-11-11
PCT/US2022/049369 WO2023086365A1 (en) 2021-11-11 2022-11-09 Compositions comprising amino lipid compounds and methods of making and use thereof

Publications (2)

Publication Number Publication Date
JP2024544953A JP2024544953A (ja) 2024-12-05
JP2024544953A5 true JP2024544953A5 (https=) 2025-11-18

Family

ID=86336672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527703A Pending JP2024544953A (ja) 2021-11-11 2022-11-09 アミノ脂質化合物を含む組成物ならびにその製造方法及び使用方法

Country Status (8)

Country Link
US (1) US20250032415A1 (https=)
EP (1) EP4429702A4 (https=)
JP (1) JP2024544953A (https=)
KR (1) KR20240141231A (https=)
CN (1) CN118338914A (https=)
AU (1) AU2022386137A1 (https=)
CA (1) CA3237998A1 (https=)
WO (1) WO2023086365A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025174765A1 (en) * 2024-02-12 2025-08-21 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
CN119685212B (zh) * 2024-12-18 2026-03-24 山东大学 链霉菌ah1901-2及其应用、萘霉素类化合物的制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3394030T (lt) * 2015-12-22 2022-04-11 Modernatx, Inc. Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
WO2018232120A1 (en) * 2017-06-14 2018-12-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
WO2019027999A1 (en) * 2017-07-31 2019-02-07 Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND USES THEREOF
EP3792246B1 (en) * 2018-03-16 2024-11-27 Kabushiki Kaisha Toshiba Biodegradable compound, lipid particle, lipid particle-containing composition, and kit
CN114901253A (zh) * 2019-08-14 2022-08-12 爱康泰生治疗公司 用于递送核酸的改进的脂质纳米颗粒

Similar Documents

Publication Publication Date Title
JP2024544953A5 (https=)
JP2023553835A5 (https=)
JP2022551185A5 (https=)
JP2021519794A5 (https=)
JP2013040159A5 (ja) 有機金属錯体
JP2024529067A5 (https=)
JP2007284431A5 (ja) 芳香族アミン化合物
JP2023166381A5 (https=)
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
JP2017052786A5 (https=)
JP2016514719A5 (https=)
JP2015505296A5 (https=)
RU2015149009A (ru) 19-нор нейроактивные стероиды и способы их применения
JP2013542218A5 (https=)
JP2009537540A5 (https=)
JP2018531218A5 (https=)
JP2024520395A5 (https=)
JP2024532768A5 (https=)
JP2005520923A5 (https=)
JP2005511595A5 (https=)
JP2010501478A5 (https=)
JP2014097964A5 (https=)
JP2006507355A5 (https=)
JP2010537034A5 (https=)
JP2006509842A5 (https=)